|
Rick Panicucci, PhD
Global Head, Chemical & Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, Inc., Massachusetts
Global Head of Chemical and Pharmaceutical Profiling (CPP) at Novartis from 2004. Responsible for Research support and early Pharmaceutical Development of all small molecule therapeutics globally. Additional responsibilities include developing novel drug delivery technologies for small molecules and large molecules including siRNA. Also holds the position of Adjunct Professor at Massachusetts College of Pharmacy.
Previously held positions include the Director of Formulation Development at Vertex Pharmaceuticals, Director of Research and Development at Symbollon Pharmaceuticals and Senior Scientist at Biogen. He started his career at Bausch & Lomb in the pre-formulation lab and was promoted to Manager of Process Development.
His education includes two post doctoral fellowships at University of California at Santa Barbara and the Ontario Cancer Institute. He received his Ph.D. in Physical Organic Chemistry from the University of Toronto.
|